HOME >> MEDICINE >> NEWS
One-on-one with pharmacists gives patients medication advantage

COLUMBUS, Ohio - After spending nearly an hour talking one-on-one with a pharmacist, participants in a new study reported using fewer medications and having far fewer drug-related problems.

Instead of having the subjects come to a pharmacy, the pharmacists came to the participants' churches.

Holding the one-on-one discussions at churches allowed people to come to an "emotionally safe, familiar and private environment, instead of the sometimes chaotic setting of a doctor's office or pharmacy," said Gerald Cable, a study co-author and a clinical assistant professor of pharmacy at Ohio State University.

"We weren't surprised at the extent of correctable medication problems we found," he said. "However, we were surprised that the participants were so willing to talk with us about these problems." More than half of the participants had kept medication past its expiration date, and nearly half reported that they had experienced adverse drug reactions.

But the intervention sessions seemed to help, as subjects reported using less medication during the six months after the one-on-one meeting than in the six months prior to the session.

"We hope that's a reflection of increased communication between the study participants an
'"/>

Contact: Gerald Cable
Cable.1@osu.edu
614-292-2492
Ohio State University
3-Jun-2002


Page: 1 2 3 4 5

Related medicine news :

1. UNC study uncovers increasing shortage of pharmacists with growing population
2. Specialist care gives better rate of survival
3. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
4. Kinder, gentler procedure gives superior results for stem cell transplants
5. Marine snail study gives insights into human brain
6. Mouse model gives insight to human hair loss
7. CT with multiplanar reconstruction gives new perspective on complex ankle fractures
8. ESA gives green light to funding for GMES
9. How brain gives special resonance to emotional memories
10. Off-label use of migraine drug gives children relief, study says
11. Study gives lowdown on high-temperature superconductivity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of ... bring their novel lifesaving device for the everyday use of parents worldwide. It ... designed to read a child’s vital signs, and detect unusual symptoms or physical ...
(Date:4/24/2017)... NEW PORT RICHEY, Fla. (PRWEB) , ... April ... ... Disease Control and Prevention (CDC), rising prescription opioid overdose deaths now claim the ... (DEA) has slashed its civil case filings against drug manufacturers, distributors, pharmacies and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively new ... is not known to have significant interactions with antiretroviral therapy (ART). Among ... levels and dampen inflammation in the bloodstream. , While lowering cholesterol and dampening ...
(Date:4/24/2017)... KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... health topics, but she has not found any of them to be very practical. ... actions to slowly and easily make changes in their health. It prompted her in ...
(Date:4/24/2017)... ... , ... “The Saint with Trin, and Omega Station”: a triple feature offering ... of published author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. ... School District teaching English. He is heavily involved in the youth group of his ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology:
Cached News: